ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,246.68
0.48%
US Tech 100
17,844.00
0.68%
다우존스 지수
39,558.11
0.32%
Bitcoin
61,659.19
0.18%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Zentalis Pharmaceuticals Inc (ZNTL)

  7. Zentalis Pharmaceuticals Inc (ZNTL) 뉴스

ZNTL

Zentalis Pharmaceuticals (ZNTL)

Zentalis Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ZNTL
일자시간출처헤드라인심볼기업
2024/05/1420:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation SummitNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/05/0720:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/05/0720:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/05/0720:00GlobeNewswire Inc.Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational ProgressNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/05/0206:30GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/04/0305:05GlobeNewswire Inc.Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024NASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/04/0206:30GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/03/0208:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/03/0107:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/03/0107:14Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/2821:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/2721:08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/2721:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/2721:00GlobeNewswire Inc.Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational UpdatesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/1606:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/1409:43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/1321:00GlobeNewswire Inc.Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences ConferenceNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/1310:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/1310:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/1310:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0609:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0609:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0609:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0609:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0311:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0311:29Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0311:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0311:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0311:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZNTLZentalis Pharmaceuticals Inc
2024/02/0207:00GlobeNewswire Inc.Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ZNTLZentalis Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:ZNTL

최근 히스토리

USI
USTECH100
US Tech 100
NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
NYSE
VZ
Verizon Communications
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BASFY
BASF (QX)
AMEX
XLV
Health Care Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
NYSE
NKE
Nike
NYSE
KO
Coca Cola
NYSE
CVX
Chevron
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유